Scientists edge closer to root causes of multiple sclerosis
Researchers led by Carles Vilariño-Güell found mutations in 12 genes believed to be largely responsible for the onset of MS.
Microglial ‘fingers’ probe dense brain structures in health and disease
New UBC research expands our understanding of the brain’s immune cells.
CREST.BD network recognized by CIHR for transformation in patient engagement
CREST.BD and its leader, Erin Michalak, received a Gold Leaf Prize for excellence in translational health research.
Wearable brain devices marketed to consumers raise ethical questions
Neuroethicist Judy Illes recommends caution with wearable brain devices
Mining 25 years of data uncovers a new predictor of age of onset for Huntington disease
UBC researchers have uncovered a genetic variant that significantly influences age of onset in patients.
Huntington drug successfully lowers levels of disease-causing protein
An international clinical trial has found that a new drug for Huntington disease is safe and lowers levels of disease-causing protein.
First-of-its-kind imaging facility to accelerate brain research at UBC
The Charles E. Fipke Integrated Neuroimaging Suite is unique, with its PET-MRI machine dedicated solely to brain-related research.
Psychedelics: A new frontier in addiction medicine
The philanthropic community steps up to fill a funding gap in psychedelic-assisted therapy for treating opioid and other substance use disorders.
Common treatment for multiple sclerosis may prolong life
Significant UBC study followed nearly 6,000 patients for more than two decades.
New approach to stroke treatment could minimize brain damage
A new treatment for stroke may soon be possible, thanks to a discovery by an international team of researchers led by UBC.